The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gazdanova A.A.

Sechenov First Moscow State Medical University

Gorodetskaya G.I.

Sechenov First Moscow State Medical University;
Scientific Center for Expert Evaluation of Medicinal Products

Perkov A.V.

Sechenov First Moscow State Medical University

Starodub M.V.

Sechenov First Moscow State Medical University

Urtaev S.R.

Sechenov First Moscow State Medical University

Prokopenko D.V.

Sechenov First Moscow State Medical University

Minakova L.A.

Sechenov First Moscow State Medical University

Cutaneous manifestations of endocrine disorders

Authors:

Gazdanova A.A., Gorodetskaya G.I., Perkov A.V., Starodub M.V., Urtaev S.R., Prokopenko D.V., Minakova L.A.

More about the authors

Read: 27044 times


To cite this article:

Gazdanova AA, Gorodetskaya GI, Perkov AV, Starodub MV, Urtaev SR, Prokopenko DV, Minakova LA. Cutaneous manifestations of endocrine disorders. Russian Journal of Clinical Dermatology and Venereology. 2022;21(2):230‑237. (In Russ.)
https://doi.org/10.17116/klinderma202221021230

Recommended articles:
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36

References:

  1. Rusak YuE, Gorshkova AV, Efanova EN. Improving the treatment efficacy of chronic dermatoses. RMJ. 2021;4:78-80. (In Russ.).
  2. Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Translational pediatrics. 2017;6(4):300-312.  https://doi.org/10.21037/tp.2017.09.08
  3. Ruzieva SKh. Dermatological manifestations of endocrine diseases. Vestnik sovremennykh issledovanij. 2018;6.1(21):85-90. (In Russ.).
  4. Shtoda YuM, Slesarenko NA, Rodionova TI, Utts SR, Karpova EN. Dermatological manifestations of diabetes mellitus. Sovremennye problemy nauki i obrazovaniya. 2014.(2):371. (In Russ.). https://www.science-education.ru/ru/article/view?id=12839
  5. Hines A, Alavi A, Davis MDP. Cutaneous Manifestations of Diabetes. Med Clin North Am. 2021;105(4):681-697. Accessed Sep 25, 2021. https://doi.org/10.1016/j.mcna.2021.04.008
  6. Coerdt KM, Zolper EG, Starr AG, Fan KL, Attinger CE, Evans KK. Cutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients. Arch Plast Surg. 2021;48(2):231-236.  https://doi.org/10.5999/aps.2020.00549
  7. García-Arpal M, Bujalance-Cabrera C, Banegas-Illescas ME, Sánchez-Caminero MP, González-Ruiz L, Villasanti-Rivas N. Scleredema diabeticorum in a patient: un uncommon etiology of restrictive lung pattern Escleredema diabeticorum en un paciente: una etiología infrecuente de patrón restrictivo pulmonar. Dermatol Online J. 2021;27(3):13030/qt71g4k3qf. PMID: 33865279.
  8. Potekaev NN, Kruglova LS, Fedotova KYu, Sharapova EN, Bobrov MA. Lichen planus as a part of syndromes: case studies. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2016;(3):17-23. (In Russ.). https://doi.org/10.17116/klinderma201615317-23
  9. Kökten N, Uzun L, Karadağ AS, Zenginkinet T, Kalcıoğlu MT. Grinspan’s Syndrome: A Rare Case with Malignant Transformation. Case reports in otolaryngology. 2018; Article 9427650. https://doi.org/10.1155/2018/9427650
  10. Otero-Rey EM, Suarez-Alen F, Peñamaria-Mallon M, Lopez-Lopez J, Blanco-Carrion A. Malignant transformation of oral lichen planus by a chronic inflammatory process. Use of topical corticosteroids to prevent this progression? Acta Odontologica Scandinavica. 2014;72(8):570-577.  https://doi.org/10.3109/00016357.2014.914570
  11. Lykova SG, Morzhanaeva MA, Nemchaninova OB, Svechnikova EV. Psoriasis in patients with metabolic syndrome: clinical aspects of the problem. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2020;19(2):214-222. (In Russ.). https://doi.org/10.17116/klinderma202019021214
  12. Svechnikova EV, Spitsyna AV, Nemchaninova OB, Lykova SG, Maksimova YuV, Maksimov VN. General genetic aspects of psoriasis and type 2 diabetes mellitus. Meditsinskij al’manakh. 2018;3(54):124-127. (In Russ.).
  13. Ufimtseva MA, Popov AA, Fedotova LV, Mylnikova ES, Bochkarev YuM, Zhunisova DS. Psoriasis and metabolic syndrome: a review. Ozhirenie i metabolism. 2020;17(4):369-374. (In Russ.). https://doi.org/10.14341/omet12517
  14. Naik PP, Farrukh SN. Clinical Significance of Diabetic Dermatopathy. Diabetes Metab Syndr Obes. 2020;13:4823-4827. https://doi.org/10.2147/DMSO.S286887
  15. Smirnova OM, Kononenko IV, Pryakhina KYu, Nagaeva KN. Lipoid necrobiosis and other skin lesions in diabetes mellitus. Sakharnyj diabet. 2007; 10(2):71-74. (In Russ.). https://doi.org/10.14341/2072-0351-5801
  16. Baccarani A, De Maria F, Pappalardo M, Pedone A, De Santis G. Necrobiosis Lipoidica Affecting the Leg: What Is the Best Treatment in a Patient with Very High Aesthetic Demand? Plast Reconstr Surg Glob Open. 2020; 8(7):e3000. https://doi.org/10.1097/GOX.0000000000003000
  17. Ketterer R, Frenk E. Hautveränderungen bei endokrinen Störungen (mit Ausnahme des Diabetes) [Skin changes in endocrine disorders (with the exception of diabetes)]. Ther Umsch. 1995;52(4):269-274. 
  18. Domingos A, Calças R, Carias E, Vidinha J, Malho Guedes A, Santos V, Agostini P, Mendonça FI, Leão Neves P. Acquired perforating dermatosis with associated complicated cellulitis and amputation in a hemodialysis patient. Clin Nephrol Case Stud. 2021;9:33-38.  https://doi.org/10.5414/CNCS110297
  19. Wang MF, Mei XL, Wang L, Lin-Feng L. Clinical characteristics and prognosis of acquired perforating dermatosis: A case report. Experimental and Therapeutic Medicine. 2020;19(6):3634-3640. https://doi.org/10.3892/etm.2020.8651
  20. Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP. Cutaneous Manifestations of Diabetes Mellitus and Prediabetes. Acta Med Port. 2019;32(6): 459-465.  https://doi.org/10.20344/amp.10738
  21. Svoboda SA, Shields BE. Cutaneous Manifestations of Nutritional Excess: Pathophysiologic Effects of Hyperglycemia and Hyperinsulinemia on the Skin. Cutis. 2021;107(2):74-78.  https://doi.org/10.12788/cutis.0173
  22. Mancino G, Miro C, Di Cicco E, Dentice M. Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin. J Endocrinol Invest. 2021;44:1571-1579. https://doi.org/10.1007/s40618-020-01492-2
  23. Kachuk YuV. Damage in case of dysfunction of the thyroid gland. Dermatovenerologiya. Kosmetologiya. Seksopatologiya. 2013;1(4):228-232. (In Russ.). https://nbuv.gov.ua/UJRN/dcs_2013_1-4_37
  24. Song X, Shen Y, Zhou Y, Lou Q, Han L, Ho JK, Ren Y. General hyperpigmentation induced by Grave’s disease: A case report. Medicine (Baltimore). 2018;97(49):e13279. Accessed Sep 25, 2021. https://doi.org/10.1097/MD.0000000000013279
  25. Malan M, Dai Z, Jianbo W, Quan SJ. Onycholysis an early indicator of thyroid disease. Pan Afr Med J. 2019;32:31.  https://doi.org/10.11604/pamj.2019.32.31.17653
  26. Stratakis CA. Skin manifestations of Cushing’s syndrome. Rev Endocr Metab Disord. 2016;17(3):283-286.  https://doi.org/10.1007/s11154-016-9399-3
  27. Lefkowitz EG, Cossman JP, Fournier JB. A Case Report of Cushing’s Disease Presenting as Hair Loss. Case Rep Dermatol. 2017;9(1):45-50.  https://doi.org/10.1159/000457898
  28. Pankiv VI. Primary adrenal insufficiency. Mezhdunarodnyj endokrinologicheskij zhurnal. 2013;3(51):110-117. (In Russ.).
  29. Molashenko NV, Sazonova AI, Troshina EA. Congenital dysfunction of the adrenal cortex in adult patients: an algorithm for diagnosis and treatment. Consilium Medicum. 2017;19(4):70-74. (In Russ.).
  30. Pankiv VI. Mineralocorticoid deficiency: etiology, pathogenesis, diagnosis, treatment approaches. Mezhdunarodnyj endokrinologicheskij zhurnal. 2012; 1(41):108-117. (In Russ.).
  31. Biryukova EV, Ganenkova ES, Lovanova MD. Chronic adrenal insufficiency in clinical practice. Consilium Medicum. 2019;21(4):103-108. (In Russ.).
  32. De Silva T, Cosentino G, Ganji S, Riera-Gonzalez A, Hsia DS. Endocrine Causes of Hypertension. Curr Hypertens Rep. 2020;22(11):97.  https://doi.org/10.1007/s11906-020-01108-3
  33. Boix J, Bigas J, Sevilla LM, Iacobone M, Citton M, Torresan F, Caroccia B, Rossi GP, Pérez P. Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes. Sci Rep. 2017;7(1):15806. https://doi.org/10.1038/s41598-017-16216-5
  34. Zhang H, Miao C, Zhang X. Hyperkeratosis lenticularis perstans in a patient with primary hyperaldosteronism. J Dtsch Dermatol Ges. 2018;16(1):72-73.  https://doi.org/10.1111/ddg.13392
  35. Ben-Shlomo A, Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24(4):256-259.  https://doi.org/10.1016/j.clindermatol.2006.04.011
  36. Degirmentepe EN, Gungor S, Kocaturk E, Kiziltac U, Adas M, Ozekinci S, Khachemoune A. Dermatologic manifestations of acromegaly: A case in point and a focused review. Dermatol Online J. 2017;23(8):13030/qt50s903qh.
  37. Demirkesen C. Skin Manifestations of Endocrine Diseases. Turk Patoloji Derg. 2015;31(1):145-154.  https://doi.org/10.5146/tjpath.2015.01321
  38. Dedov II, Melnichenko GA, Mokrysheva NG, Rozhinskaya LYa, Kuznetsov NS, Pigarova EA, Eremkina AK, Egshatyan LV, Mamedova EO, Krupinova YuA. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2016;62(6):40-77. (In Russ.). https://doi.org/10.14341/probl201662640-77
  39. Eremkina AK, Kovaleva EV. Hypoparathyroidism: etiology, clinical presentation, modern methods and treatment. Al’manakh klinicheskoj meditsiny. 2016;44(4):477-492. (In Russ.). https://doi.org/10.18786/2072-0505-2016-44-4-477-492
  40. Jabbour SA. Cutaneous manifestations of endocrine disorders: A guide for dermatologists. Am J Clin Dermatol. 2003;4(5):315-331.  https://doi.org/10.2165/00128071-200304050-00003
  41. Keen MA, Shah IH, Sheikh G. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study. Indian Dermatol Online J. 2017;8(2):104-110.  https://doi.org/10.4103/2229-5178.202275
  42. Yilmaz B, Yildiz BO. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders. Front Horm Res. 2019;53:108-119.  https://doi.org/10.1159/000494907
  43. Kępczyńska-Nyk A, Muszel M, Radziszewski M, Wocial K. Chora lat 19 z hirsutyzmem, otyłością i zmianami skórnymi o typie rogowacenia ciemnego (Woman 19-old with hirsutism, obesity and acanthosis nigricans). Pol Merkur Lekarski. 2016;41(243):141-144. Polish. PMID: 27755516.
  44. Uzuncakmak TK, Akdeniz N, Karadag AS. Cutaneous manifestations of obesity and the metabolic syndrome. Clin Dermatol. 2018;36(1):81-88.  https://doi.org/10.1016/j.clindermatol.2017.09.014
  45. Potekaev NN, Zhukovsky RO, Shnakhova LM, Tikhomolova MM. Acanthosis nigricans. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2011;9(2):36-38. (In Russ.).
  46. Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient. J Am Acad Dermatol. 2019;81(5):1037-1057. https://doi.org/10.1016/j.jaad.2018.12.070
  47. Panevin TS, Molashenko NV, Troshina EA, Golovenko EN. Autoimmune polyglandular syndrome of adults: current ideas about predictors development of damage of a myocardium and diagnostics of components of a disease. Klinicheskaya i eksperimental’naya tireoidologiya. 2018;14(2):92-99. (In Russ.). https://doi.org/10.14341/ket9641
  48. Horino T, Ogasawara M, Ichii O, Terada Y. Autoimmune polyglandular syndrome type 3 variant in rheumatoid arthritis. Rom J Intern Med. 2020;58(1): 40-43.  https://doi.org/10.2478/rjim-2019-0024

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.